LLY

Eli Lilly and Co
340.00
-2.10 (-0.61%)
Company Name Stock Ticker Symbol Market Type
Eli Lilly and Co LLY NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-2.10 -0.61% 340.00 19:55:04
Open Price Low Price High Price Close Price Prev Close
344.68 339.46 347.80 340.50 342.10
more quote information »

Recent News

Date Time Source Heading
1/27/202314:58DJNFDA Approves Eli Lilly's Jaypirca to Treat Lymphoma Patients
1/27/202314:07PRNUSU.S. FDA Approves Jaypirca™ (pirtobrutinib), the First and..
1/26/202310:00PRNUSLilly Supports Direct Relief's Efforts to Expand Access to..
1/25/202316:14EDGARAmended Statement of Ownership (sc 13g/a)
1/24/202306:30PRNUSLilly Plans to Invest Additional $450 million at..
1/20/202309:00PRNUSUS FDA accepts supplemental New Drug Application for..
1/19/202318:00PRNUSU.S. Food and Drug Administration Issues Complete Response..
1/19/202316:47EDGARStatement of Changes in Beneficial Ownership (4)
1/19/202316:45EDGARStatement of Changes in Beneficial Ownership (4)
1/19/202316:43EDGARStatement of Changes in Beneficial Ownership (4)
1/19/202316:40EDGARStatement of Changes in Beneficial Ownership (4)
1/19/202316:38EDGARStatement of Changes in Beneficial Ownership (4)
1/19/202310:00PRNUSLilly Confirms Date and Conference Call for Fourth-Quarter..
1/04/202310:00PRNUSLilly to Participate in the J.P. Morgan Healthcare..
12/22/202206:54DJNProQR Therapeutics Rises on Expanded Lilly Partnership
12/20/202217:16EDGARStatement of Changes in Beneficial Ownership (4)
12/20/202217:14EDGARStatement of Changes in Beneficial Ownership (4)
12/20/202217:11EDGARStatement of Changes in Beneficial Ownership (4)
12/20/202217:10EDGARStatement of Changes in Beneficial Ownership (4)
12/20/202217:08EDGARStatement of Changes in Beneficial Ownership (4)
12/14/202204:15PRNUSLilly and EVA Pharma Announce Collaboration to Enhance..
12/13/202208:00DJNEli Lilly Expects 2023 Sales Growth, Plans Launch of Four..
12/13/202207:04EDGARCurrent Report Filing (8-k)
12/13/202206:45PRNUSLilly Announces 2023 Financial Guidance, Plans to Launch up..
12/12/202217:30PRNUSLoxo@Lilly Presents Updated Pirtobrutinib Data from the..
12/12/202216:06DJNEli Lilly & Co. Raises Dividend 15% to $1.13/Share
12/12/202215:26PRNUSLilly Announces 15% Dividend Increase, First-Quarter 2023..
12/07/202208:00PRNUSPhase III trial demonstrated Jardiance® is the first SGLT2..
12/06/202215:00PRNUSLilly Announces Updated Data from the Verzenio®..
12/05/202212:16EDGARStatement of Changes in Beneficial Ownership (4)
12/02/202211:30EDGARStatement of Changes in Beneficial Ownership (4)
12/01/202208:41PRNUSLilly Completes Acquisition of Akouos Expanding Efforts to..
12/01/202208:37TRMNEli Lilly’s (NYSE:LLY) COVID-19 Therapy Loses FDA..
11/30/202218:00PRNUSLilly Shares Positive Donanemab Data in First Active..
11/30/202206:50PRNUSLilly and Akouos Announce Expiration of Akouos Tender Offer
11/29/202210:00PRNUSLilly Confirms Date and Conference Call for 2023 Financial..
11/22/202222:35TRMNSVB Securities Sticks to Its Buy Rating for Eli Lilly & Co..
11/22/202217:41EDGARStatement of Changes in Beneficial Ownership (4)
11/22/202217:32EDGARStatement of Changes in Beneficial Ownership (4)
11/22/202217:28EDGARStatement of Changes in Beneficial Ownership (4)
11/22/202217:21EDGARStatement of Changes in Beneficial Ownership (4)
11/22/202217:16EDGARStatement of Changes in Beneficial Ownership (4)
11/21/202209:00PRNUSLilly Announces Details of Presentations at 2022 San Antonio..
11/16/202210:00PRNUSLilly to Participate in Evercore ISI HealthCONx Conference
11/11/202211:35DJNEli Lilly Down Over 6%, on Pace for Largest Percent Decrease..
11/07/202214:35EDGARStatement of Changes in Beneficial Ownership (4)
11/07/202211:30PRNUSLilly to begin rollout of Tempo® Personalized Diabetes..
11/04/202212:22EDGARStatement of Changes in Beneficial Ownership (4)
11/04/202210:30PRNUSLandmark EMPA-KIDNEY trial showed significant benefit of..
11/03/202212:17EDGARStatement of Changes in Beneficial Ownership (4)